{"schema_version":"secwatch.filing_event.v1","accession":"0001321732-23-000032","form_type":"8-K","ticker":"PEN","cik":"0001321732","company_name":"Penumbra Inc","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.381842+00:00","generated_at":"2026-06-19T02:03:28.862092+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"medium","headline":"Penumbra Q4 2022 revenue $221.2M, up 8.4% YoY; operating income $4.8M vs loss $40.1M","bullets":["Q4 revenue $221.2M (+8.4% YoY, +10.5% constant currency); full year $847.1M (+13.3%).","US revenue Q4 $157.1M (+8.8%); vascular product revenue $129.7M (+14.2%), neuro $91.5M (+1.2%).","Gross margin improved to 62.6% from 61.5% YoY.","Operating income $4.8M vs loss $40.1M in Q4 2021; non-GAAP operating income $7.2M vs $2.5M.","Full year revenue $847.1M, up 13.3% YoY; US revenue $591.7M (+12.1%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001321732-23-000032","json":"https://secwatch.observer/filing/0001321732-23-000032.json","markdown":"https://secwatch.observer/filing/0001321732-23-000032.md","text":"https://secwatch.observer/filing/0001321732-23-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000032/0001321732-23-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000032/pen-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T02:03:28.862092+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c1cfdff17c18af3833a04d80572903e3bfb7d86","claim":"Penumbra Inc reported the fourth quarter ended December 31, 2022 results: revenue $221.2 million.","evidence_excerpt":"Revenue of $221.2 million for the fourth quarter of 2022, an increase of 8.4% compared to revenue of $204.0 million for the fourth quarter of 2021, or an increase of 10.5% in constant currency (a non-GAAP measure) 1 .","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000032/0001321732-23-000032-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$221.2 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"749e7ec4ad1c1faf06fe6f0e349c398a76263f29","claim":"Penumbra Inc reported the full year ended December 31, 2022 results: revenue $847.1 million.","evidence_excerpt":"Revenue of $847.1 million for the full year 2022, an increase of 13.3% compared to revenue of $747.6 million for the full year 2021, or an increase of 15.5% in constant currency 1 .","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1321732/000132173223000032/0001321732-23-000032-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2022"},{"label":"Revenue","value":"$847.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}